FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

663811000001107: Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16656101000001117 Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66014001000001116 Plaquenil 200mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely hydroxychloroquine sulfate 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Hydroxychloroquine sulfate false Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Is a Plaquenil true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Hydroxychloroquine sulfate true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) 60 tablet 6 x 10 tablets Is pack of False Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) 60 tablet 6 x 10 tablets Has AMP True Plaquenil 200mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start